Skip to main content
Have a personal or library account? Click to login
Clinical Epidemiology of Hypertension in Rural Thailand: A Nationwide Cross-Sectional Study Cover

Clinical Epidemiology of Hypertension in Rural Thailand: A Nationwide Cross-Sectional Study

Open Access
|Dec 2025

References

  1. World Health Organization. Hypertension 2023 [Internet]. [cited 2024 March 22] Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.
  2. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957980. DOI: 10.1016/S0140-6736(21)01330-1
  3. Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Goldstein A, et al. Trends in hypertension prevalence, awareness, treatment, and control in the Thai population, 2004 to 2020. BMC Public Health. 2024;24:3149. DOI: 10.1186/s12889-024-20643-1
  4. Sakboonyarat B, Rangsin R. Characteristics and clinical outcomes of people with hypertension receiving continuous care in Thailand: A cross-sectional study. The Lancet Regional Health - Southeast Asia. 2023;21:100319. DOI: 10.1016/j.lansea.2023.100319
  5. Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: Updating and enhancing the American Heart Association’s construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18e43. DOI: 10.1161/CIR.0000000000001078
  6. Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. The Lancet Global Health. 2019;7:e1332e1345.
  7. World Health Organization. ICD-10: International statistical classification of diseases and related health problems: tenth revision 2016 [Internet]. [cited 2024 March 22] Available from: https://icd.who.int/browse10/2016/en#/I10-I15.
  8. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Progress in Cardiovascular Nursing. 2000;15(3):9096. DOI: 10.1111/j.1751-7117.2000.tb00211.x
  9. Wongpakaran N, Wongpakaran T. The Thai version of the PSS-10: An investigation of its psychometric properties. Biopsychosocial Medicine. 2010;4:6. DOI: 10.1186/1751-0759-4-6
  10. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine. 2006;166:10921097. DOI: 10.1001/archinte.166.10.1092
  11. Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8:46. DOI: 10.1186/1471-244X-8-46
  12. Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. Journal of the Medical Association of Thailand. 2021;104:17291738. DOI: 10.35755/jmedassocthai.2021.10.12199
  13. Juraschek SP, Ishak AM, Mukamal KJ, Wood JM, Anderson TS, Cohen ML, et al. Impact of 30- versus 60-second time intervals between automated office blood pressure measurements on measured blood pressure. Hypertension. 2021;78(5). DOI: 10.1161/HYPERTENSIONAHA.121.17876
  14. Gabriel J, Anne L-AM, Thiele I-TI, Mae SC, Elizabeth P-P. Impact of waist circumference measurement variation on the diagnosis of metabolic syndrome. Philippine Journal of Internal Medicine. 2010;48(3):717.
  15. Loehr LR, Rosamond WD, Poole C, Marie McNeill A, Chang PP, Folsom AR, et al. Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study. Circulation Heart Failure. 2009;2(1):1824. DOI: 10.1161/CIRCHEARTFAILURE.108.813782
  16. Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points – A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. European Heart Journal. 2016;37(25):19441958. DOI: 10.1093/eurheartj/ehw152
  17. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethnicity & Disease. 2006;16(1):286291.
  18. National Center for Health Statistics. Glossary – Alcohol 2018 [Internet]. [cited 2024 March 18] Available from: https://www.cdc.gov/nchs/nhis/alcohol/alcohol_glossary.htm.
  19. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-Country reliability and validity. Medicine and Science in Sports and Exercise. 2003;35(8):13811395. DOI: 10.1249/01.MSS.0000078924.61453.FB
  20. Brown WJ, Trost SG, Bauman A, Mummery K, Owen N. Test-retest reliability of four physical activity measures used in population surveys. Journal of Science and Medicine in Sport. 2004;7(2):205215. DOI: 10.1016/S1440-2440(04)80010-0
  21. Organization WH. WHO STEPS surveillance manual: The WHO STEPwise approach to chronic disease risk factor surveillance. World Health Organization; 2005.
  22. Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mahonen M, Blackett KN, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. International Journal of Epidemiology. 2011;40(1):139146. DOI: 10.1093/ije/dyq165
  23. Prineas RJ, Crow RS, Zhang Z-M. The Minnesota code manual of electrocardiographic findings. Springer Science & Business Media; 2009. DOI: 10.1007/978-1-84882-778-3
  24. Yu Z, Song J, Cheng L, Li S, Lu Q, Zhang Y, et al. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis. PLoS One. 2021;16(1):e0246305. DOI: 10.1371/journal.pone.0246305
  25. Kwon D, Yi JJ, Ohrr H, Yi SW. Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults. Medicine (United States) 2019;98(36):e17013. DOI: 10.1097/MD.0000000000017013
  26. Aekplakorn W. Thai National Health Examination Survey VI (2019-2020) 2019 [Internet]. [cited 2023 October 3] Available from: https://online.fliphtml5.com/bcbgj/znee/#p=187.
  27. Rata Mohan DS, Jawahir S, Manual A, Abdul Mutalib NE, Mohd Noh SN, Ab Rahim I, et al. Gender differences in health-seeking behaviour: Insights from the National Health and Morbidity Survey 2019. BMC Health Services Research. 2025;25(1):900. DOI: 10.1186/s12913-025-13020-0
  28. World Health Organization. Hypertension care in Thailand: best practices and challenges, 2019. Bangkok: World Health Organization. Country Office for Thailand; 2019.
  29. Quiambao A, Malekpour M-R, Golestani A, Heidari-Foroozan M, Ghamari S-H, Abbasi-Kangevari M, et al. World health Organization’s guidance for tracking non-communicable diseases towards sustainable development goals 3.4: An initiative for facility-based monitoring. EClinicalMedicine. 2025;85:103304. DOI: 10.1016/j.eclinm.2025.103304
  30. Benjamin IJ, Kreutz R, Olsen MH, Schutte AE, Lopez-Jaramillo P, Frieden TR, et al. Fixed-dose combination antihypertensive medications. The Lancet. 2019;394(10199):637638. DOI: 10.1016/S0140-6736(19)31629-0
  31. Khonputsa P, Veerman LJ, Bertram M, Lim SS, Chaiyakunnaphruk N, Vos T. Generalized cost-effectiveness analysis of pharmaceutical interventions for primary prevention of cardiovascular disease in Thailand. Value in Health Regional Issues. 2012;1(1):1522. DOI: 10.1016/j.vhri.2012.03.019
  32. Meelab S, Bunupuradah I, Suttiruang J, Sakulrojanawong S, Thongkua N, Chantawiboonchai C, et al. Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: A cross-sectional study. PLoS One. 2019;14:e0212572. DOI: 10.1371/journal.pone.0212572
  33. Augustin A, Coutts L, Zanisi L, Wierzbicki AS, Shankar F, Chowienczyk PJ, et al. Impact of therapeutic inertia on long-term blood pressure control: A Monte Carlo simulation study. Hypertension. 2021;77(4):13501359. DOI: 10.1161/HYPERTENSIONAHA.120.15866
  34. Thai Hypertension Society. 2024 Thai guidelines on the treatment of hypertension. Chiang Mai: Trick Think; 2024.
  35. Thai Hypertension Society. 2024 Thai Guidelines on the Treatment of Hypertension [Internet]. [cited 2025 November 29] Available from: https://thaihypertension.org/2024-guideline/.
  36. Eriksson M, Sundberg LR, Santosa A, Lindgren H, Ng N, Lindvall K. Health behavioural change–the influence of social-ecological factors and health identity. International Journal of Qualitative Studies on Health and Well-Being. 2025;20(1):2458309. DOI: 10.1080/17482631.2025.2458309
  37. Chaturvedi A, Zhu A, Gadela NV, Prabhakaran D, Jafar TH. Social determinants of health and disparities in hypertension and cardiovascular diseases. Hypertension. 2024;81(3):387399. DOI: 10.1161/HYPERTENSIONAHA.123.21354
  38. Causland FRM, Sacks FM, Forman JP. Marital status, dipping and nocturnal blood pressure: Results from the Dietary Approaches to Stop Hypertension trial. Journal of Hypertension. 2014;32(4):756761. DOI: 10.1097/HJH.0000000000000107
  39. Umberson D, Montez JK. Social relationships and health: a flashpoint for health policy. Journal of Health and Social Behavior. 2010;51 Suppl:S54S66. DOI: 10.1177/0022146510383501
  40. Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, et al. A community-based intervention for managing hypertension in rural South Asia. New England Journal of Medicine. 2020;382(2):717726. DOI: 10.1056/NEJMoa1911965
  41. Chailimpamontree W, Kantachuvesiri S, Aekplakorn W, Lappichetpaiboon R, Sripaiboonkij Thokanit N, Vathesatogkit P, et al. Estimated dietary sodium intake in Thailand: A nationwide population survey with 24-hour urine collections. Journal of Clinical Hypertension. 2021;23(4):744754. DOI: 10.1111/jch.14147
  42. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6). DOI: 10.1161/HYPERTENSIONAHA.120.15026
  43. Jabbarzadeh Ganjeh B, Zeraattalab-Motlagh S, Jayedi A, Daneshvar M, Gohari Z, Norouziasl R, et al. Effects of aerobic exercise on blood pressure in patients with hypertension: A systematic review and dose-response meta-analysis of randomized trials. Hypertension Research. 2024;47(2):385398. DOI: 10.1038/s41440-023-01467-9
  44. Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: A systematic review and meta-analysis. Cardiovascular Diabetology. 2017;16(1):110. DOI: 10.1186/s12933-017-0590-y
  45. Dua S, Bhuker M, Sharma P, Dhall M, Kapoor S. Body mass index relates to blood pressure among adults. North American Journal of Medicine and Science. 2014;6(2):8995. DOI: 10.4103/1947-2714.127751
  46. Sakboonyarat B, Rangsin R, Kantiwong A, Mungthin M. Prevalence and associated factors of uncontrolled hypertension among hypertensive patients: A nation-wide survey in Thailand. BMC Research Notes. 2019;12:380. DOI: 10.1186/s13104-019-4417-7
  47. Kumar RB, Aronne LJ. Review of multimodal therapies for obesity treatment: Including dietary, counseling strategies, and pharmacologic interventions. Techniques in Gastrointestinal Endoscopy. 2017;19(1):1217. DOI: 10.1016/j.tgie.2016.11.003
  48. Taylor MK, Sullivan DK, Ellerbeck EF, Gajewski BJ, Gibbs HD. Nutrition literacy predicts adherence to healthy/unhealthy diet patterns in adults with a nutrition-related chronic condition. Public Health Nutrition. 2019;22(12):21572169. DOI: 10.1017/S1368980019001289
  49. Liampeng S, Wongkliawrian N, Junlawakkananon S, Prapaso A, Panichnantho N, Kiengsiri S, et al. Effect of the weight-loss program using daily self-weighing combined with personalized counseling led by village health volunteers in adults with obesity in a rural community, Thailand: A randomized controlled trial. BMC Primary Care. 2023;24(1):226. DOI: 10.1186/s12875-023-02178-3
  50. Olateju IV, Ogwu D, Owolabi MO, Azode U, Osula F, Okeke R, et al. Role of behavioral interventions in the management of obesity. Cureus. 2021;13(9):e18080. DOI: 10.7759/cureus.18080
  51. Powell-Wiley TM, Brewer LC, Burke LE, Hernandez R, Landsbaugh Kaar J, Kepper M, et al. Role of technology in promoting heart healthy behavior change to increase equity in optimal cardiovascular health: A scientific statement from the American Heart Association. Circulation. 2025;151(18). DOI: 10.1161/CIR.0000000000001314
  52. Vathesatogkit P, Woodward M, Tanomsup S, Ratanachaiwong W, Vanavanan S, Yamwong S, et al. Cohort profile: The electricity generating authority of Thailand study. International Journal of Epidemiology. 2012;41(2):359365. DOI: 10.1093/ije/dyq218
  53. Faculty of Medicine Ramathibodi Hospital MU. Thai CV risk score 2015 [Internet]. [cited 2025 November 17] Available from: https://www.rama.mahidol.ac.th/cardio_vascular_risk/thai_cv_risk_score/tcvrs_en.html.
  54. Satian P, Aramcharoen S, Chotikarn P, Triukose ST. An external validation of Thais’ cardiovascular 10-year risk assessment in the southern Thailand. Region 11 Medical Journal. 2022;36(2):6573. DOI: 10.14456/reg11med.2022.16
  55. Jinatongthai P, Dongtai W, Aonsuebsai B, Towongsricharoen P, Songmuang T, Watcharathanakij S, et al. Validation of the pooled cohort risk score and the Thai CV risk score for atherosclerosis-cardiovascular disease (ASCVD) risk prediction at Warinchamrab hospital. Thai Bulletin of Pharmaceutical Sciences. 2021;16(2):7181. DOI: 10.69598/tbps.16.2.71-81
  56. Sakboonyarat B, Poovieng J, Jongcherdchutrakul K, Mungthin M, Rangsin R, Pongpinigpinyo S, et al. Abstract P1075: Computer-based technology enhancing cardiovascular disease risk assessment by health workers in rural communities in Thailand: A preliminary analysis. Circulation. 2025;151. DOI: 10.1161/cir.151.suppl_1.P1075
  57. Sakboonyarat B, Poovieng J, Rangsin R. Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand. Clinical Hypertension. 2024;30(1):8. DOI: 10.1186/s40885-024-00267-8
  58. Scheltens T, De Beus MF, Hoes AW, Rutten FH, Numans ME, Mosterd A, et al. The potential yield of ECG screening of hypertensive patients: The Utrecht Health Project. Journal of Hypertension. 2010;28(7):12571533. DOI: 10.1097/HJH.0b013e328339f95c
  59. Peguero JG, Lo Presti S, Perez J, Issa O, Brenes JC, Tolentino A. Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. Journal of the American College of Cardiology. 2017;69(13):16941703. DOI: 10.1016/j.jacc.2017.01.037
DOI: https://doi.org/10.5334/gh.1515 | Journal eISSN: 2211-8179
Language: English
Submitted on: Aug 17, 2025
Accepted on: Dec 19, 2025
Published on: Dec 31, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Boonsub Sakboonyarat, Kamakshi Lakshminarayan, Ram Rangsin, Mathirut Mungthin, Kanlaya Jongcherdchootrakul, Jaturon Poovieng, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.